Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Complete Response Letters
Drug Review Profiles
Scrip
Sandoz Will Wait A Decade On Amantadine
Patent-Litigation Settlement Permits 2030 Launch
Jan 06 2020
•
By
Aidan Fry
Sandoz has agreed to wait until 2030 to launch a generic of Gocovri in the US • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin